Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 4/20 | 0.49 |
| ▸ | TSHR | P16473 | 3/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TOP2A | P11388 | 1/20 | 0.45 |
| ▸ | CMA1 | P23946 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27573199 | 0.83 | CMA1 (0.51) | ALDH1A1PKMGAAMAPTKDM4E | |
| SCHEMBL1768224 | 0.82 | ALDH1A1 (0.54) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL7684043 | 0.82 | ALDH1A1 (0.54) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL19732308 | 0.82 | ALDH1A1 (0.54) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL10566633 | 0.82 | SIGMAR1 (0.45) | ALDH1A1PKMTSHRALOX15POLB | |
| SCHEMBL7433479 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL4631721 | 0.81 | ALDH1A1 (0.53) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL7148471 | 0.79 | ALDH1A1 (0.62) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL19726570 | 0.78 | ALDH1A1 (0.51) | ALDH1A1PKMGAATSHRALOX15 | |
| SCHEMBL1768222 | 0.78 | ALDH1A1 (0.51) | ALDH1A1PKMGAATSHRALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6620580-B2 | Photographic element comprising a support bearing a blue light sensitive record containing at least three layers having different levels of light sensitivity arranged in the order slowest to fastest with the slowest layer closest to the | EASTMAN KODAK COMPANY | 2003-09-16 | — | — | US | claimed |
| US-20030143498-A1 | Color negative element containing triple-coated blue record and method of imaging using same | EASTMAN KODAK COMPANY | 2003-07-31 | — | — | US | claimed |
| EP-0191621-A2 | Dopamine-bêta-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1986-08-20 | — | — | EP | claimed |
| WO-2025021868-A1 | TRAF2 INHIBITORS FOR THE TREATMENT OF CANCER AND OTHER DISEASES | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) | 2025-01-30 | — | — | WO | disclosed |
| WO-2017093543-A2 | ANTI-BACTERIAL COMPOUNDS | AUSPHERIX LIMITED (GB) | 2017-06-08 | — | — | WO | disclosed |
| US-20090181942-A1 | TRICYCLIC COMPOUNDS | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2009-07-16 | — | — | US | disclosed |
| EP-1939205-A1 | TRICYCLIC COMPOUND | Daiichi Sankyo Company, Limited (JP) | 2008-07-02 | — | — | EP | disclosed |
| EP-1312978-A1 | Color negative element containing triple-coated blue record and method of imaging using same | EASTMAN KODAK COMPANY (US) | 2003-05-21 | — | — | EP | disclosed |
| EP-1016914-B1 | Photographic element containing pyrazolone pug releasing coupler and imaging process employing same | EASTMAN KODAK CO (US) | 2002-02-27 | — | — | EP | disclosed |
| US-6153369-A | CONTAINING A 4-ARYLOXYPYRAZOL-5-ONE COUPLER | EASTMAN KODAK COMPANY (US) | 2000-11-28 | — | — | US | disclosed |
| EP-1016914-A1 | Photographic element containing pyrazolone pug releasing coupler and imaging process employing same | EASTMAN KODAK COMPANY (US) | 2000-07-05 | — | — | EP | disclosed |
| US-4912024-A | Mixture of couplers | EASTMAN KODAK COMPANY (US) | 1990-03-27 | — | — | US | disclosed |
| EP-0348134-A2 | Photographic materials having releasable compounds | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-12-27 | — | — | EP | disclosed |
| EP-0348139-A2 | Photograhic materials and process | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-12-27 | — | — | EP | disclosed |
| EP-0347850-A2 | Photographic material having combination of releasable compounds | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1989-12-27 | — | — | EP | disclosed |
| US-4810811-A | CHEMICAL INTERMEDIATES | SMITHKLINE BECKMAN CORPORATION (US) | 1989-03-07 | — | — | US | disclosed |
| US-4707488-A | HYPOTENSIVE AGENTS | SMITHKLINE BECKMAN CORPORATION (US) | 1987-11-17 | — | — | US | disclosed |
| US-4663461-A | Process for preparing 1-H-tetrazole-5-thiols | AMERICAN HOME PRODUCTS CORPORATION (US) | 1987-05-05 | — | — | US | disclosed |
| EP-0191621-A2 | Dopamine-bêta-hydroxylase inhibitors | SMITHKLINE BECKMAN CORPORATION (US) | 1986-08-20 | — | — | EP | disclosed |
| US-4526978-A | Process for preparing 1-H-tetrazole-5-thiols and intermediate compounds | AMERICAN HOME PRODUCTS CORPORATION (US) | 1985-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090181942-A1 | TRICYCLIC COMPOUNDS | FDFT1, COASY, HMGCR | ALDH1A1 1587/4885PKM 2660/4885GAA 922/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.